D. McGonagle Et Al. , "Reply to: Behcet's disease: an MHC-I-opathy?," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.35, no.2, 2017
McGonagle, D. Et Al. 2017. Reply to: Behcet's disease: an MHC-I-opathy?. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.35, no.2 .
McGonagle, D., Aydin, S. Z., Gül, A., MAHR, A., & Direskeneli, H., (2017). Reply to: Behcet's disease: an MHC-I-opathy?. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.35, no.2.
McGonagle, D. Et Al. "Reply to: Behcet's disease: an MHC-I-opathy?," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.35, no.2, 2017
McGonagle, D. Et Al. "Reply to: Behcet's disease: an MHC-I-opathy?." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.35, no.2, 2017
McGonagle, D. Et Al. (2017) . "Reply to: Behcet's disease: an MHC-I-opathy?." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.35, no.2.
@article{article, author={D. McGonagle Et Al. }, title={Reply to: Behcet's disease: an MHC-I-opathy?}, journal={CLINICAL AND EXPERIMENTAL RHEUMATOLOGY}, year=2017}